Final published version
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - Controlled release of chlorhexidine diacetate from a porous methacrylate system
T2 - Supercritical fluid assisted foaming and impregnation
AU - Gong, K.
AU - Braden, M.
AU - Patel, M.P.
AU - Rehman, I.U.
AU - Zhang, Z.
AU - Darr, J.A.
PY - 2007
Y1 - 2007
N2 - The release of chlorhexidine diacetate (CX) from a self-curing polymeric system based on poly(ethylmethacrylate) and tetrahydrofurfurylmethacrylate (PEM/THFM) was developed in this study. Supercritical fluid assisted impregnation and foaming was employed for preparing porous CX-PEM/THFM drug release system. X-ray diffraction (XRD) and differential scanning calorimetry (DSC) show that the crystallinity of CX significantly decreased after supercritical processing, whilst Raman spectroscopy suggested a hydrogen bonding interaction between the CX and PEM in the product. A UV-Vis dissolution study revealed that the drug release rate is almost as seven times faster in the SCF processed drug delivery system than conventional cured samples. © 2007 Wiley-Liss, Inc. and the American Pharmacists Association.
AB - The release of chlorhexidine diacetate (CX) from a self-curing polymeric system based on poly(ethylmethacrylate) and tetrahydrofurfurylmethacrylate (PEM/THFM) was developed in this study. Supercritical fluid assisted impregnation and foaming was employed for preparing porous CX-PEM/THFM drug release system. X-ray diffraction (XRD) and differential scanning calorimetry (DSC) show that the crystallinity of CX significantly decreased after supercritical processing, whilst Raman spectroscopy suggested a hydrogen bonding interaction between the CX and PEM in the product. A UV-Vis dissolution study revealed that the drug release rate is almost as seven times faster in the SCF processed drug delivery system than conventional cured samples. © 2007 Wiley-Liss, Inc. and the American Pharmacists Association.
KW - Amorphous
KW - Chlorhexidine diacetate
KW - Controlled release
KW - PEM/THFM
KW - Supercritical fluid
KW - chlorhexidine acetate
KW - methacrylic acid
KW - poly(ethyl methacrylate)
KW - tetrahydrofurfurylmethacrylate
KW - unclassified drug
KW - article
KW - controlled release formulation
KW - crystal structure
KW - differential scanning calorimetry
KW - dissolution
KW - drug delivery system
KW - drug formulation
KW - drug release
KW - foaming
KW - Raman spectrometry
KW - supercritical fluid
KW - X ray diffraction
U2 - 10.1002/jps.20850
DO - 10.1002/jps.20850
M3 - Journal article
VL - 96
SP - 2048
EP - 2056
JO - Journal of Pharmaceutical Sciences
JF - Journal of Pharmaceutical Sciences
SN - 0022-3549
IS - 8
ER -